SYM vs TMO · rev $2.25B vs P/E 24, rev $44.56B
Symbotic Inc (SYM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Symbotic Inc (SYM) is a specialty industrial machinery company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported SYM revenue for 2025-09-27 was $2.25B. Net income was -$91.0M. Revenue was up 298.0% from 2024-09-28 to 2025-09-27. SYM currently screens at market cap $24.25B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
SYM currently screens at market cap $24.25B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the SYM and TMO stock pages for the full models.
Not investment advice.